MicroRNA-874 inhibits cell proliferation and invasion by targeting cyclin-dependent kinase 9 in osteosarcoma

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• MicroRNAs (miRNAs) are crucial regulators in human cancer development.
• miR-874 is recognized as a tumor suppressor with reduced expression in various malignancies, including osteosarcoma.
• The precise molecular mechanisms underlying miR-874's function in osteosarcoma remain largely unexplored.

Purpose of the Study:

• To elucidate the functional role and molecular mechanism of miR-874 in osteosarcoma.
• To identify direct target genes of miR-874 involved in osteosarcoma progression.
• To investigate the therapeutic potential of the miR-874/target gene pathway in osteosarcoma.

Main Methods:

• Utilized a dual-luciferase reporter system to validate the direct interaction between miR-874 and its target gene.
• Employed miR-874 mimics to assess the impact on gene expression in osteosarcoma cells.
• Analyzed gene expression levels in osteosarcoma tissues and cell lines.
• Performed gain-of-function experiments by overexpressing the target gene.

Main Results:

• Confirmed cyclin-dependent kinase 9 (CDK9) as a direct target of miR-874.
• Demonstrated that miR-874 mimics significantly suppressed CDK9 expression in osteosarcoma.
• Observed elevated CDK9 levels and an inverse correlation between miR-874 and CDK9 expression in osteosarcoma tissues (R=-0.725).
• Showed that CDK9 overexpression counteracted the inhibitory effects of miR-874 on osteosarcoma cell proliferation and invasion.

Conclusions:

• miR-874 functions as a tumor suppressor in osteosarcoma by directly targeting and downregulating CDK9.
• The miR-874/CDK9 axis plays a significant role in regulating osteosarcoma cell proliferation and metastasis.
• Targeting the miR-874/CDK9 pathway presents a promising therapeutic avenue for osteosarcoma treatment.